News
NTRBW
1.375
0.00%
0.000
Weekly Report: what happened at NTRBW last week (0902-0906)?
Weekly Report · 09/09 10:19
Based on the provided financial report articles, the title of the article is: "Form 10-Q: Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Press release · 09/03 23:12
Weekly Report: what happened at NTRBW last week (0826-0830)?
Weekly Report · 09/02 10:22
Weekly Report: what happened at NTRBW last week (0819-0823)?
Weekly Report · 08/26 10:20
Weekly Report: what happened at NTRBW last week (0812-0816)?
Weekly Report · 08/19 10:13
Weekly Report: what happened at NTRBW last week (0805-0809)?
Weekly Report · 08/12 10:14
Weekly Report: what happened at NTRBW last week (0729-0802)?
Weekly Report · 08/05 10:20
Weekly Report: what happened at NTRBW last week (0722-0726)?
Weekly Report · 07/29 10:15
Weekly Report: what happened at NTRBW last week (0715-0719)?
Weekly Report · 07/22 10:15
NUTRIBAND RECEIVES NOTICE OF ALLOWANCE FOR U.S. TRADEMARK COVERING AVERSA(TM) ABUSE DETERRENT TECHNOLOGY
Reuters · 07/15 11:05
Weekly Report: what happened at NTRBW last week (0708-0712)?
Weekly Report · 07/15 10:13
Weekly Report: what happened at NTRBW last week (0701-0705)?
Weekly Report · 07/08 10:14
Weekly Report: what happened at NTRBW last week (0624-0628)?
Weekly Report · 07/01 10:14
Weekly Report: what happened at NTRBW last week (0617-0621)?
Weekly Report · 06/24 10:18
Weekly Report: what happened at NTRBW last week (0610-0614)?
Weekly Report · 06/17 10:14
Weekly Report: what happened at NTRBW last week (0603-0607)?
Weekly Report · 06/10 10:15
Weekly Report: what happened at NTRBW last week (0527-0531)?
Weekly Report · 06/03 10:17
Weekly Report: what happened at NTRBW last week (0520-0524)?
Weekly Report · 05/27 10:19
Weekly Report: what happened at NTRBW last week (0513-0517)?
Weekly Report · 05/20 10:15
Weekly Report: what happened at NTRBW last week (0506-0510)?
Weekly Report · 05/13 10:20
More
Webull provides a variety of real-time NTRBW stock news. You can receive the latest news about Nutriband through multiple platforms. This information may help you make smarter investment decisions.
About NTRBW
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.